- Published on 04 May 2016
In early February 2016, we reported on rumors communicated by Bloomberg that speculated on the sale of AudioNova by the investment fund that holds the company, HAL Trust.
This has now become a reality, well almost. In a press release dated May 4, Sonova announced the signature of an agreement with the Dutch distributor with the aim of acquiring the network for 830 million Euros.
The agreement was signed with the owner of AudioNova, HAL Investments, based in Rotterdam, and will be submitted to the competition authorities. An opinion is expected during the second half of 2016, says Sonova.
AudioNova is one of the leaders in the distribution of hearing aids in Europe, with more than 1,300 centers in eight different countries. Lukas Braunschweiler, CEO of Sonova, says: “The acquisition of AudioNova is a significant step in further advancing our strategy of offering a full range of hearing solutions along with the professional audiological services which are instrumental to achieve the optimal result for our customers. I am convinced that the combination of our well established and complementary retail networks represents a strong base for future growth.”
After acquiring the French chain AuditionSanté in 2008, Sonova is now reinforcing its presence in the retail sector. With the 1,300 AudioNova stores, this buyout by the Swiss holding group could give rise to one of the largest distribution networks in Europe.
The financing will be ensured by UBS and will result in a debt/EBITA ratio of about 1.2. The share buyback program announced in November 2014 is suspended until further notice.
The standards applied in testing for US authorisation for self-fitting hearing aids may "jeopardise the hearing health of consumers", says the Hearing Industries Association (HIA) in a letter to the issuing body, the Food and Drug Administration (FDA).
Widespread backing in US audiology supports the introduction of the bipartisan, bicameral Medicare Audiologist Access and Services Act of 2019, already before the US House of Representatives and soon to be put to the Senate.
If the mice are right, there is a drug fix for age-related hearing loss just around the next bureaucratic corner: the hormone aldosterone, combined with anti-inflammatory medicine, can rejuvenate hearing, says the team behind the development.
Audiologists from Australia's Royal Brisbane and Women's Hospital (RBWH) have helped update a recently developed app—HEAROES—designed to help new cochlear implant (CI) users adjust to their new sound environment.
The number of US citizens with eustachian tube dysfunction (ETD), barring those with recent colds, was previously estimated at under 1%, but a new study puts the figure at 4.6%, some 11m people. And the researchers say their figure may underestimate the condition's true prevalence.
Phonak, the world’s leading hearing aid provider, has launched Marvel 2.0, "the next generation of Marvel technology developed to give hearing aid wearers even more hearing performance, more connectivity and more choice".[ ... ]